logo-loader
viewOptiBiotix Health PLC

OptiBiotix secures exclusive manufacturing agreement for CE marked SlimBiome

OptiBiotix Health plc (LON:OPTI) chief executive Stephen O'Hara tells Proactive London's Andrew Scott they've agreed a production, packaging and supply agreement for its CE Marked weight management product.

Italy’s Nutrilinea will formulate and distribute SlimBiome Medical, which also has medical device status, in boxes of 30 single sachet doses for sale across its network and the UK firm’s growing list of partners.

Quick facts: OptiBiotix Health PLC

Price: 61.5 GBX

AIM:OPTI
Market: AIM
Market Cap: £52.55 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of OptiBiotix Health PLC named herein, including the promotion by the Company of OptiBiotix Health PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

OptiBiotix's Stephen O'Hara hails new safety status for LPLDL and recent awards

OptiBiotix Health PLC’s (LON:OPTI) Stephen O'Hara speaks to Proactive London's Andrew Scott soon after the news its LPLDL probiotic had been granted ‘generally recognised as safe’ (GRAS) status by the US Food and Drug Administration (FDA). Its subsidiary, ProBiotix Health Ltd, received the...

3 weeks ago

2 min read